A prospective cohort study of Baoji oral liquid in the treatment of gastrointestinal influenza

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400084754

Enrollment

Unknown

Registered

2024-05-23

Start date

2024-05-25

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal influenza

Interventions

A exposed cohort (Prescription Baoji oral liquid treatment):None

A non-exposed cohort (Without prescription Baoji oral liquid and other similar Chinese medicine treatment):None

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: (1) Meet the Western medical diagnostic criteria for gastrointestinal influenza; (2) In line with the external wind cold, gastrointestinal dysfunction or external heat dampness, gastrointestinal dysfunction and TCM syndrome diagnosis criteria; (3) within 48 hours of onset of illness; (4) Maximum body temperature within 24 hours =38?; (5) Age 18-65 years old; (6) Sign informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria: (1) Diarrhea, influenza, etc. caused by infectious viruses; (2) Allergic to the investigational drug; (3) The researcher thinks that others are not suitable to participate in the researcher.

Design outcomes

Primary

Measure	Time frame
Gastrointestina influenza recovery time;	—

Secondary

Measure	Time frame
The effectiveness of gastrointestinal influenza after treatment;Disappearance rate of single symptom;	—

Countries

China

Contacts

Public ContactYuning Bai

Guang 'anmen Hospital, China Academy of Chinese Medical Sciences

byn-1973@163.com+86 133 6626 6838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026